Allscripts Appoints Vice President and Managing Director, EMEA

AllscriptsAllscripts (NASDAQ: MDRX) has appointed a new leader for its business in the UK while strengthening its focus on Europe, the Middle East and Africa. Richard Strong, who was Vice President, International Services, is taking up the new role of vice president and managing director, EMEA.

Strong said his first priorities for the coming year would be to increase the number of NHS trusts signed-up to deploy the Sunrise electronic patient record and to raise awareness of the capabilities of its dbMotion population health management solution.

He said he would also be looking to bring new clinical and departmental systems to the UK, while taking elements of the UK approach to the Middle East, where there is keen interest in population health management, as well as in administrative and clinical systems.

"Allscripts is well-established in the UK and popular with ourcustomers," he said. "I am looking forward to building onthe excellent work we have already achievedwithin the region with the Global Digital Exemplar programme in the UK and with customers that have benefited from our clinical wrap approach."

"I want more people to hear about what Allscripts has delivered at some of the top performing trusts in the United Kingdom, which use dbMotion to share information with GPs and explore population health management. As we develop our strategy for EMEA, I want more organisations to benefit from the solutions that we are already deploying across the UK."

Strong started his career in the NHS in London, where his work as a biomedical scientist drew him into the implementation of laboratory information systems. He went on to work for Siemens Healthcare Systems and then Cerner UK, where he played a key role in the implementation of electronic patient record systems in the capital, before becoming its director of European services.

He also worked in both UK and international roles for Dell, before joining Allscripts in 2016, to help grow its global ambitions.

Alan Fowles, President Allscripts International, said: "The creation of the new role of vice president and managing director, EMEA, shows our commitment to growing Allscripts as a global company."

"Richard's background in the health tech industry, and his deep understanding of the requirements of health and care organisations in the UK, across Europe, and in the Middle East makes him the ideal choice for the role, and we are confident that this will enable more organisations to benefit from Allscripts’ sector-leading solutions, knowledge and experience."

Allscripts' rapid expansion and high levels of customer satisfaction were recognised in a 2018 KLAS performance report on the European electronic record market, which noted that it had gone from one Sunrise customer in 2011 to eight when the report was written.

The company is currently running a clinical wrap campaign to support trusts that want to digitise without the cost and disruption caused by scrapping their existing patient administration systems and other IT investments.

This is in line with the NHS Long Term Plan’s recognition to complete the digitisation of hospitals through an extension of the GDE programme and an accelerated roll-out of EPRs. The plan also gave strong support to the development and deployment of population health management.

Some of the additional products that Allscripts will be bringing to the UK from other regions include Sunrise Surgical Care with iPro Anaesthesia, the Patient Flow with Census Logic hospital status application, and Follow My Health, a patient engagement platform, as well as integrated electronic document management.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...